GDF11 and obesity disorder: Since the expansion of WAT mass seen in obesity involves hyperplasia, hypertrophy, inflammation, and glucose turnover in adipocytes, the beneficial effects of GDF11 therapy in obesity are likely to occur at multiple levels.